PD-L1 induces epithelial-to-mesenchymal transition via activating SREBP-1c in renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PD-L1 induces epithelial-to-mesenchymal transition via activating SREBP-1c in renal cell carcinoma

Published:2015-07-04 Issue:8 Volume:32 Page:
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Wang Yiwei,Wang Hang,Zhao Qi,Xia Yu,Hu Xiaoyi,Guo Jianming

Funder

Scientific Research Projects of Shanghai under the Shanghai Science and Technology Commission

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12032-015-0655-2.pdf

Reference21 articles.

1. Chen W, et al. Report of cancer incidence and mortality in China, 2010. Ann Transl Med. 2014;2(7):61.

2. Siegel R, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29.

3. Li P, et al. Regional geographic variations in kidney cancer incidence rates in European countries. Eur Urol. 2015;67(6):1134–41.

4. Bianchi M, et al. Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol. 2012;23(4):973–80.

5. Zhi WI, Kim JJ. An update on current management of advanced renal cell cancer, biomarkers, and future directions. Ann Cancer Res. 2014;1(2):1–10.

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Double agents in immunotherapy: Unmasking the role of antibody drug conjugates in immune checkpoint targeting;Critical Reviews in Oncology/Hematology;2024-10

2. Correlation Of E-cadherin, Vimentin, CD206, PD-1, PD-L1 Expression With Clinicopathological Factors And Prognosis In Oral Squamous Cell Carcinoma;2024-06-28

3. PD-L1 promotes oncolytic virus infection via a metabolic shift that inhibits the type I IFN pathway;Journal of Experimental Medicine;2024-06-13

4. The Immune Checkpoint Protein PD-L1 Regulates Ciliogenesis and Hedgehog Signaling;Cells;2024-06-08

5. PD-L1 knockdown suppresses vasculogenic mimicry of non-small cell lung cancer by modulating ZEB1-triggered EMT;BMC Cancer;2024-05-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3